Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 20 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $1.533 million which beat the analyst consensus estimate of $540.000 thousand by 183.89 percent. This is a 3.51 percent increase over sales of $1.481 million the same period last year.